ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,026Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 973

$794K Total Retail Price of All Prescriptions

Rank: 29 out of 973

497 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 497 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,546 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 829 665 1 1
LISINOPRIL 781 630 2 3
LEVOTHYROXINE SODIUM 623 508 3 2
FUROSEMIDE 590 545 4 6
OMEPRAZOLE 553 445 5 5
METFORMIN HCL 464 355 6 8
ATENOLOL 385 336 7 16
HYDROCHLOROTHIAZIDE 371 328 8 11
AMLODIPINE BESYLATE 354 279 9 7
WARFARIN SODIUM 349 341 10 10
HYDROCODONE-ACETAMINOPHEN 312 256 S3 11 4
POTASSIUM CHLORIDE 303 298 12 9
GABAPENTIN 294 265 13 12
BENZTROPINE MESYLATE 269 79 R 14 124
LISINOPRIL-HYDROCHLOROTHIAZIDE 231 207 15 25
LOVASTATIN 218 210 16 38
KLOR-CON M20 196 178 17 64
DILTIAZEM ER 191 181 18 109
CITALOPRAM HBR 177 149 19 14
TAMSULOSIN HCL 172 129 20 28
DIGOXIN 167 162 21 32
ALENDRONATE SODIUM 167 95 21 24
CARVEDILOL 161 161 23 27
POLYETHYLENE GLYCOL 3350 161 146 23 36
DIVALPROEX SODIUM ER 155 64 25 148
KLOR-CON 10 149 139 26 128
GLIMEPIRIDE 141 139 27 41
RISPERIDONE 140 75 28 65
ENALAPRIL MALEATE 137 131 29 55
METOPROLOL TARTRATE 132 116 30 13
FLUTICASONE PROPIONATE 128 95 31 35
PRAVASTATIN SODIUM 124 78 32 22
FINASTERIDE 122 96 33 90
RANITIDINE HCL 115 56 34 45
ZOLPIDEM TARTRATE 114 108 35 20
ATORVASTATIN CALCIUM 113 105 36 15
QUETIAPINE FUMARATE 110 86 37 70
SERTRALINE HCL 105 91 38 21
CARBIDOPA-LEVODOPA 102 101 39 71
DOXAZOSIN MESYLATE 102 102 39 87
ALLOPURINOL 100 81 41 29
DONEPEZIL HCL 100 74 41 26
METOPROLOL SUCCINATE 99 82 43 17
LANTUS 97 83 44 39
AZITHROMYCIN 91 78 45 47
RISPERDAL CONSTA 85 57 46 187
NOVOLOG 85 25 46 82
NAMENDA 84 81 48 31
DOXYCYCLINE HYCLATE 83 77 49 96
CIPROFLOXACIN HCL 82 78 50 57
OXYBUTYNIN CHLORIDE ER 81 51 51 125
AMITRIPTYLINE HCL 80 73 R 52 52
INSULIN SYRINGE 80 50 52 153
PREDNISONE 80 61 52 33
BUPROPION XL 79 62 55 222
SYNTHROID 76 65 56 50
FLUOXETINE HCL 74 74 57 56
TRAZODONE HCL 74 63 57 48
BUMETANIDE 74 74 57 103
BYSTOLIC 73 68 60 110
TRAMADOL HCL 73 69 60 18
SEROQUEL 69 50 62 150
FAMOTIDINE 68 68 63 61
MIRTAZAPINE 67 48 64 43
NITROGLYCERIN PATCH 63 63 65 173
DIVALPROEX SODIUM 61 39 66 86
DILANTIN 61 18 66 240
OLANZAPINE 60 17 68 122
CLONIDINE HCL 60 43 68 67
GEMFIBROZIL 58 50 70 83
VENLAFAXINE HCL ER 57 43 71 95
MELOXICAM 57 38 71 23
IPRATROPIUM-ALBUTEROL 55 55 73 115
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 24 74 76
PANTOPRAZOLE SODIUM 52 52 75 37
HUMALOG 51 51 76 127
BENICAR 50 50 77 231
PAROXETINE HCL 50 43 77 66
GLIPIZIDE 50 37 77 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 12, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.